SEC Form 4 · accession 0001209191-15-064063

ImmunityBio, Inc. · IBRX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — President and COO · Director

Period of report

Jul 27, 2015

Accepted (ET)

Aug 5, 2015 · 4:31 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001326110

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1	Jul 27, 2015	M	185,150	$0.00	A	3,355,690	D
Common Stock	Jul 27, 2015	F	96,612	$25.00	D	3,259,078	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Restricted Stock Units^F1,F2	—	Jul 27, 2015	A	370,300	A	—	—	Common Stock	370,300	370,300	D
Restricted Stock Units^F1,F2	—	Jul 27, 2015	M	185,150	D	—	—	Common Stock	185,150	185,150	D
Stock Option (right to buy)^F3	$25.00	Jul 27, 2015	A	555,450	A	—	Jul 27, 2025	Common Stock	555,450	555,450	D

F1Each restricted stock unit ("RSU") represents a contingent right to receive one share of NantKwest, Inc. common stock.
F2Subject to the reporting person's continuing to be a Service Provider (as defined in the 2015 Equity Incentive Plan) through each applicable vesting date, the restricted stock units ("RSUs") will vest as follows: 50% of the RSUs vested on July 27, 2015, and 50% of the RSUs will vest on July 27, 2016.
F3Subject to the award recipient's continuing to be a Service Provider (as defined in the 2015 Equity Incentive Plan) through each applicable vesting date, the option will vest as follows: 50% of the shares subject to the option vested and became exercisable on July 27, 2015, and 50% of the shares subject to the option shall vest and become exercisable on July 27, 2016.